Mycoplasma Testing Market Size Worth $1.87 Billion by 2027: Grand View Research, Inc.

SAN FRANCISCO, Aug. 18, 2022 /PRNewswire/ -- The global mycoplasma testing market size is expected to reach a value of USD 1.87 billion by 2027, expanding at a CAGR of 14.9%, according to a new report by Grand View Research, Inc. The demand for mycoplasma testing products is anticipated to rise in near future with growing R&D investments in the field of life sciences. Huge opportunities in the life sciences segment are spurring market growth. Rising investment in biotechnology and pharmaceutical industries with rising healthcare spending is expected to further fuel the growth.

Key Insights & Findings from the report:

• In 2019, kits and reagents dominated the market and is also expected to showcase the highest CAGR over the forecast period, owing to its increasing usage in mycoplasma tests
• The Polymerase Chain Reaction (PCR) segment held the largest market share in 2019 owing to the delivery of fast and accurate results associated with this technology
• Cell line testing is anticipated to exhibit the highest CAGR over the forecast period due to the increased risk of cell line contamination
• In 2019, pharmaceutical and biotechnology companies accounted for the largest mycoplasma testing market share due to rising research activities in drug discovery and development
• North America dominated the market in 2019 owing to rising healthcare spending levels and government funding for life science-related research
• Asia Pacific is expected to expand at an exponential CAGR during the forecast period, attributed to an increase in healthcare spending along with rising in demand for better infrastructure in laboratory and clinical research
• Some of the key market players are Merck KGaA; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing Laboratories, Inc.

Read 120-page full market research report for more Insights, "Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kit & Reagents, Services), By Technology (PCR, ELISA, Direct Assay, Microbial Culture), By Application, By End Use, And Segment Forecasts, 2020 - 2027", published by Grand View Research.

Mycoplasma Testing Market Growth & Trends

Government initiatives in the form of awareness campaigns for chronic diseases, such as cancer are also encouraging research-based activities. The National Research Council's Industrial Research and Assistance Program (NRC-IRAP) provides technological support to small and medium scale life science companies in Canada involved in product development and innovation. According to Saudi Arabia's 2030 Vision, its government is promoting the growth of pharmaceutical industries due to the fact that only 30% of its medication requirements are produced locally. Such factors are expected to drive market growth.

Mycoplasma contamination of cell culture is a growing concern for most researchers for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are conducted, which is expected to increase the demand for the related products and hence, the market growth.

Mycoplasma Testing Market Segmentation

Grand View Research has segmented the global mycoplasma testing market on the basis of product, technology, application, end-use, and region:

Mycoplasma Testing Market - Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
• Kits & Reagents
• PCR Assays
• Nucleic Acid Detection Kits
• Stains
• Elimination Kits
• Standards & Controls
• Others
• Services

Mycoplasma Testing Market - Technology Outlook (Revenue, USD Million, 2016 - 2027)

• PCR
• ELISA
• Direct Assay
• Indirect Assay
• Microbial Culture Techniques
• Enzymatic Methods

Mycoplasma Testing Market - Application Outlook (Revenue, USD Million, 2016 - 2027)

• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

Mycoplasma Testing Market - End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Academic Research Institutes
• Cell Banks
• Contract Research Organizations
• Pharmaceutical & Biotechnology Companies
• Others

Mycoplasma Testing Market - Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Asia Pacific
• Japan
• China
• India
• South Korea
• Singapore
• Australia
• Latin America
• Brazil
• Mexico
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE

Check out more related studies published by Grand View Research:

• Hereditary Testing Market - The global hereditary testing market size is expected to reach USD 13.6 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.2% from 2022 to 2030. Key factors driving the market are the declining cost of sequencing and the availability of genetic tests at a lower price.
• HPV Testing And Pap Test Market - The global HPV testing and Pap test market size is expected to reach USD 7.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.4% from 2021 to 2028. The introduction of innovative tests, increasing awareness programs, rising public-private investments, and high incidence of HPV infections are some of the factors anticipated to foster market growth during the forecast period.
• Hemato Oncology Testing Market - The global hemato oncology testing market size is expected to reach USD 7.2 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.6% from 2020 to 2027. Key drivers for the market include rising incidences of leukaemia, lymphoma, myeloproliferative neoplasms, and multiple myeloma.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Grand View Compass | Astra ESG Solutions 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg